Forecast: Import of Adrenal Cortical Hormones to China

The forecasted import of adrenal cortical hormones to China demonstrates a steady growth trajectory from 2024 to 2028. Starting at $2.0253 billion in 2024, it is projected to rise to $2.3442 billion by 2028. In 2023, the imports stood at $1.945 billion, showing a consistent increase over the previous years.

Year-on-year growth rates indicate a stable increase, with an average annual growth rate (CAGR) of approximately 3.6% over the five-year period from 2024 to 2028. Such trends emphasize ongoing demand and probable expansion in pharmaceutical needs within China.

Future trends to watch for include potential impacts from regulatory changes in China, shifts in global supply chains, and innovations in hormone therapies that could affect import volumes and values. Monitoring these factors will be crucial for stakeholders to make informed strategic decisions.